News Center

Home page

Peak Report

News reports

The spikes in my eyes

Release time:

2020-08-14

The peak

■ Jiang Xiaomeng

in my eyes will be the 11th anniversary of the peak start-up 60# and the 38 year of my work in the peak. From a young and ignorant teenager to now, my temples have begun to turn white. I have witnessed the nearly 2/3 course of the peak, including glory and depression, but more hope and longing.

Fortune magazine has reported that the average life expectancy of small and medium-sized enterprises in the United States is less than 7 years, while that of large enterprises is less than 40 years. The average life span of China's small and medium-sized enterprises is 2.5 years, and the average life span of group enterprises is 7 to 8 years. Among the many enterprises in our country, very few have the same peak life as us.

The peak with history

The development of the peak has experienced many great turning points worthy of memory and commemoration, such as setting up cement factory, cross-industry acquisition, merger, diversified operation, integration of pharmaceutical industry... Fortunately, I am a witness to these great events, even a witness.

When I entered the factory, in 1980 , Jinhua Cement Factory was still in the stage of coexistence of ordinary vertical kilns and mechanical vertical kilns. At that time, in the firing workshop, most of the feeding and unloading in the production process depended on manual work. When commuting in winter, you can often see the "brilliant" image of workers wearing hoods, working cotton-padded jackets, and rice basins under their armpits. Because the buttons of the cotton-padded jacket are easy to fall off, some employees still root straw ropes in their waists. The working conditions at that time could not be compared with those now. The dust was flying when adding and unloading materials. At the end of the day, everyone became the same appearance-because they were wearing masks, there were two black shadows on the bridge of the nose, and their bodies were covered in gray. Some people had too much dust on their faces and their eyebrows looked white.

Due to the lack of economy at that time, cement was regarded as a "tight commodity". The roads outside the factory area were full of cars buying cement, large trucks and small tractors, with long lines and even overnight queues. Sometimes it took two or three days for their turn. One winter when it snowed heavily and blocked the road, vehicles transporting limestone could not get in, and production was about to stop. At that time, I was still working in the raw material workshop. The factory organized employees to sweep snow and sweep all the way to the Kowloon mine along the Shuanglong Highway.

Although the working environment is so difficult, we have a sense of superiority regardless of cadres or employees, because we are workers!

With the progress of science and technology and the development of enterprises, 20th century 80# In the mid-1950s, Jianfeng established two branch factories and three branch factories successively through cooperation with township enterprises. Later, he established a building materials group and built the first batch of rotary kiln production lines in Zhejiang Province, which was later Jinma Factory. After entering 21nd century, we went out of the basin and built factories in Fuyang across regions. Until now, Jianfeng Cement has taken root in many provinces and cities across the country.

The strength of the enterprise has been enhanced, and the metropolis has tried to develop across industries. Zhejiang Jianfeng Communication Cable Company, which was invested and constructed in the early

90 s of the last century, was the first step in the development of Jianfeng across industries. As the first general manager of a cable company, I started from scratch to supplement basic cable courses, engaged in construction, production, and market with my colleagues, and sold peak cables to most provinces and cities across the country. In 1996 , Jianfeng cross-regional merger of Linhai Pharmaceutical Factory, reorganization of the establishment of Zhejiang Jianfeng Haizhou Pharmaceutical Co., Ltd., to build a raw material drug production base. This requires considerable boldness when talents, technology and other factors were not available at that time. Although this first step was not satisfactory and later withdrew, this merger accumulated experience and trained a team for the development of Jianfeng in the pharmaceutical field. Only then did it acquire Jinhua Biochemical Pharmaceutical Factory, set up Jianfeng Pharmaceutical Company, and took a stake in Tianshili Group, finally forming a development pattern of cement and pharmaceutical dual main businesses.

Culturable Spikes

Spikes are the only and permanent place of work in my life. After so many years of work, I am full of feelings for the big family of spike. One of the important reasons why the peak can still forge ahead after ups and downs is that we have a strong vitality of corporate culture, profound cultural accumulation, the enterprise spirit of "unity and struggle, realistic innovation, determination to rise to the top, and always climb the peak". There is a corporate work style of "pragmatic and enterprising, steady behavior, standardized management, and strong implementation.

Peak is a cultural group that knows awe and gratitude. Every peak person has a strong sense of honor and responsibility. Every time they encounter difficulties, all employees, regardless of department or position, will deal with them together. When encountering conflicts of interest, everyone will consciously put the company's interests first. When colleagues encounter difficulties, all employees will lend a helping hand and the enterprise will give meticulous care. We also do our best to give care, support and help to the old employees who have contributed to the peak, such as the annual condolences and subsidies for employees in difficulties, visits by sick employees, seminars for retired employees, etc. are all good witnesses. In many important events, such as Wenchuan earthquake relief, hope primary school donation, "five water governance" and so on, can always see the figure of the peak... This is our culture, our atmosphere.

The culture of the peak is an upward and progressive culture, as well as a culture of struggle, competition and innovation. Because of this, it is possible to develop from a small cement plant with an annual output of

tons to a cross-industry and cross-regional comprehensive enterprise group, and finally form a development strategy of "cooperative innovation to strengthen the main business; standardize science and seek development". It has created the current achievements of the peak.

Peak of Continuous Innovation and Development

Peak is a dynamic and continuous development and innovation enterprise. It is precisely because of the endogenous desire for development that the peak has created one brilliant after another. The peak cement industry of

has experienced technological innovation from Puli kiln to mechanical vertical kiln and then to rotary kiln. The industrial layout has gone from the small mountain depression in the suburbs of Jinhua to central China, southwest China and even all parts of the country. From working in Jinhua to working in Pu'er, which is now as far away as

3800 kilometers; "Jianfeng" brand cement is a famous brand product in Zhejiang, Hubei, Yunnan and other provinces and cities; all environmental protection indicators have reached or led the international and domestic standards, and the production process and technical indicators are among the best in the country. It is in cost control, quality control, The profit indicators of tons of cement are all ahead of the same industry, and this year has achieved the best results in history. The

peak pharmaceutical industry has grown from scratch, from small to large, and now has

76 document numbers, exceeding the sales of 10 .1 billion yuan. It has recruited talents from all walks of life in the country and trained a large number of teams who are loyal to the peak, love their posts and work hard, bear hardships and stand hard work, have combat effectiveness and professional qualities. In Tianjin, we have Tianjin Jianfeng Natural Products Company, a leading enterprise of plant extracts in China; in Jinhua, we have recently built a large-scale Jinxi pharmaceutical base and set up a Sino-German joint venture Jinder Baby Drug Company; this year, we have also participated in Beijing Huibaoyuan Biotechnology Company ...... While the pharmaceutical territory continues to expand, the health industry sector centered on Jianfeng Health Technology Company is also showing its embryonic form.

Science and technology is the first productive force for the development of enterprises, and it is also the basis for the development of the peak pharmaceutical industry. Over the years, relying on the cooperation units of two professional research institutions and a provincial new drug research and development center, a provincial academician expert workstation and three national postdoctoral mobile stations, the research and development progress, quality and cost indicators of peak pharmaceutical products are in the forefront of the industry, and have obtained more than 20 national invention patents. The "Jianfeng" trademark held by Jianfeng Pharmaceutical Company is recognized as a well-known trademark in China, and there are patents of Jianfeng Pharmaceutical in the United States, Germany and other countries. Gatifloxacin, a national first-class new drug, won the first prize for scientific and technological progress in Zhejiang Province. The national first-class anti-tumor drug

DPT under development is also the first major national innovation project in Jinhua's history. Many products have also been listed as the national high-tech industrialization demonstration project, the national key new product plan project and the national torch plan project. Cefmenoxime hydrochloride for injection has also created a history of over 100 million yuan in sales of single products; peak Pharmaceutical has also been rated as a national high-tech enterprise for more than 10 years.

Now, the peak is about to enter the 107 60 year, which is worthy of our pride and celebration, but there is still a long way to go and a lot of work to be done before our vision of "a century-old enterprise. On the road in the future, we will still encounter many difficulties and uncertainties, but as long as all employees have a strong sense of responsibility and mission, do everything well, and take every step well, our dreams will definitely be realized., We are worthy of being the inheritors of peak spirit and peak career.

Finally, I would also like to thank the old peak people of all ages for their efforts in the cause of peak. We will not forget those old leaders, old employees, and old colleagues who have worked hard for the peak cause. Their conscientious and selfless dedication is the source and driving force of the development of the enterprise, and it also inspires generations of peak people to move forward courageously on the road of a century-old peak.

More information

Yunnan peak through the safety standard secondary acceptance

On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate

2020

07-30

Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory

News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Accident-free factory creation enters "second season"

At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open

2020

07-31

What will the Chinese Medicine Act bring us?

At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.

2020

07-31

< 1...49 50 51...61 > 跳转到页